Science
6.4
China trial: iron-based cancer therapy shows 84% efficacy in advanced cases
Published 8 h ago1 sourceEvidence: Reported
SeverityHighAssessedDeveloping storySouth China Morning PostLow-rated sourceCN
HealthReportedMedium
5.0
Merck, Moderna eye next steps after early personalized cancer vaccine success
Executives from Merck and Moderna discussed ongoing collaboration on personalized mRNA cancer vaccines paired with Keytruda, following initial trial success. The path forward remains exploratory, with efficacy and regulatory hurdles unresolved. This signals continued momentum in a high-value oncology pipeline but no new clinical data.
Score Breakdown
Mosaic Score5.0
Model confidence0.7
Significance0.5
Source credibility0.1
Related signals
8 foundHealth
4.9
Poland faces shortage of 500 oncologists as residency slots go unfilled
Published 2 d ago1 sourceEvidence: Reported
SeverityModerateRzeczpospolitaLow-rated sourcePL
Health
4.8
Bosnian Official Warns Cancer Drug Shortages Threaten Patient Rights
Published 2 d ago1 sourceEvidence: Reported
SeverityModerateN1 BosniaLow-rated sourceBA
Health
4.8
Daraxonrasib nearly doubles pancreatic cancer survival; EU approval recommended
Published 1 d ago1 sourceEvidence: Reported
SeverityModerateEl FinancieroLow-rated sourceEU
Health
4.7
Verastem KRAS G12D inhibitor shows early promise in pancreatic cancer
Published 2 d ago1 sourceEvidence: Unknown
SeverityModerateAssessedDeveloping storySTAT NewsLow-rated sourceUS
Health
2.1
Russia Registers Nimotuzumab-Based Cancer Drug Nimolancim
Published 2 d ago1 sourceEvidence: Reported
InterfaxLow-rated sourceRU
Health
8.3
CDC deploys disease detectives as Pennsylvania measles outbreak kills six
Published 4 h ago4 sourcesEvidence: Reported
SeverityHighAssessedDeveloping storyGuardian WorldLow-rated sourceUS
Health
6.9
Cychlorphine, opioid deadlier than fentanyl, detected in LA; standard tests miss it
Published 1 d ago1 sourceEvidence: Reported
SeverityHighAssessedDeveloping storyIndependent UKUS